Journal of Medicinal Chemistry p. 1538 - 1544 (1991)
Update date:2022-09-26
Topics:
Dow
Bechle
Chou
Clark
Hulin
Stevenson
A series of benzyloxazolidine-2,4-diones, containing oxazole-based side chains, were found to lower blood glucose levels in the genetically obese ob/ob mouse. Incorporation of a benzofuran structural element in these compounds provides greatly enhanced in vivo potency. The syntheses and structure-activity relationships for this series are detailed.
View MoreBeijing Mashi Fine Chemical Co.,Ltd.
Contact:+86-10-61271592
Address:Room 506, Section B, Kaichi Mansion, Industrial Development
Kunshan Yalong Trading Co,.Ltd
Contact:86-512-57621185
Address:805-807 Room Hongqiao Mansion ,1088 West Qianjin Road, Kunshan, Jiangsu，China
ShangHai Original Economy-Trade Develop Co.,Ltd.,
Contact:86-21-68552131
Address:shanghai
ClickChem Technology Co., Limited
Contact:+86-0310-6519966/0531-52893837
Address:No.750 Shunhua Road, High-Tech Zone, Jinan city, Shandong China
Tianjin Jiuri New Materials Co., Ltd.
Contact:+86-22-58889220
Address:C-5/6, Vison Hill, No.1 Gonghua Road, Huayuan Hi-tech Park, Tianjin, China.
Doi:10.1021/ja01591a049
(1956)Doi:10.1016/j.carres.2013.04.008
(2013)Doi:10.1016/0022-328X(91)80081-T
(1991)Doi:10.1021/jm200608k
(2011)Doi:10.1016/j.bmcl.2014.10.031
(2014)Doi:10.1016/j.saa.2011.04.089
(2011)
